Clinical Trial Update: Transdiagnostic Cognitive Behavioral Treatment for Anxiety [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 clinical trial update evaluating transdiagnostic cognitive behavioral treatment for anxiety disorders; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Snippet

Sponsor: VA Office of Research and Development | Conditions: Anxiety Disorders | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-08-28